S100A6 and neoplasm: In the present study, we have extended the value of S100A6 to include it as an OVCA serum biomarker by demonstrating positive expression in human OVCA using immunohistochemistry, as well as an association between S100A6 serum level and tumor burden in both mice and human patients.